Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 100997
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100997
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100997
Table 5 The top 20 most popular keywords
Rank | Keyword | Counts | Rank | Keyword | Counts |
1 | Expression | 574 | 11 | T-cells | 205 |
2 | Chemotherapy | 454 | 12 | Microsatellite instability | 202 |
3 | Prognosis | 349 | 13 | Blockade | 184 |
4 | Open-label | 315 | 14 | PD-L1 | 171 |
5 | Survival | 279 | 15 | Colorectal-cancer | 163 |
6 | Nivolumab | 268 | 16 | Gastroesophageal junction | 161 |
7 | Tumor microenvironment | 252 | 17 | Dendritic cells | 150 |
8 | Cells | 238 | 18 | Biomarker | 149 |
9 | Double-blind | 226 | 19 | Breast-cancer | 139 |
10 | Therapy | 206 | 20 | Regulatory t-cells | 128 |
- Citation: Yuan Z, Wang JH, Cui H, Wang SY, Wei B, Cui JX. Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots. World J Gastrointest Oncol 2025; 17(3): 100997
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/100997.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.100997